IL2 and cancer: To summarize our study, NCPDIAC caused a slight but definite increase of IL-2 during short-term and mid- to long-term (weeks to months) exposure periods and induced NK cell killing activities due to the recurrent and accumulated elevation of IL-2, as well as a slight upregulation of immune status in individuals to result in protection against inflammation and the occurrence of cancers.